HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Panel Needs Outside Expertise To Continue Parabens Re-Review

This article was originally published in The Rose Sheet

Executive Summary

CIR's experts tabled their re-review of parabens safety earlier this month in light of new animal research indicating developmental/reproductive effects in the offspring of rats that were orally administered relatively low butylparaben doses. The panel also issued an insufficient data announcement for preservative polyaminopropyl biguanide.

You may also be interested in...



CIR To Hear From P&G Expert With Parabens Re-Review Pending

George Daston, Victor Mills Society research fellow at Procter & Gamble, will help the Cosmetic Ingredient Review Expert Panel make sense of recently received developmental and reproductive toxicity (DART) findings as it proceeds with a re-review of parabens' safety

CIR News In Brief: No Conclusion Reached On PHMB; Endocrine Activity Guidance; More

At its Sept. 11-12 meeting in Washington, the Cosmetic Ingredient Review Expert Panel finalized reports for various protein and peptide ingredient families, among others, and advanced six tentative reports. The panel issued a tentative insufficient data conclusion for broad-spectrum preservative polyaminopropyl biguanide, with concerns about sensitization continuing to weigh on the group.

CIR Expert Panel Finalizes 2018 Review Priorities At June Meeting

Fourteen cosmetic ingredients are up for first looks by the CIR panel in 2018. Also at its June meeting, the group issued two final ingredient reports and five tentative reports, as well as two insufficient data announcements, and tabled its parabens re-review in order to solicit outside expertise on new DART data.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS109319

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel